001     140001
005     20240321220727.0
024 7 _ |a 10.1074/jbc.RA118.002776
|2 doi
024 7 _ |a pmid:29700109
|2 pmid
024 7 _ |a pmc:PMC5995519
|2 pmc
024 7 _ |a 0021-9258
|2 ISSN
024 7 _ |a 1067-8816
|2 ISSN
024 7 _ |a 1083-351X
|2 ISSN
024 7 _ |a altmetric:39598280
|2 altmetric
037 _ _ |a DZNE-2020-06323
041 _ _ |a English
082 _ _ |a 540
100 1 _ |a Tretter, Jana Ylva
|b 0
245 _ _ |a A high-content screen for small-molecule regulators of epithelial cell-adhesion molecule (EpCAM) cleavage yields a robust inhibitor.
260 _ _ |a Bethesda, Md.
|c 2018
|b Soc.60645
264 _ 1 |3 online
|2 Crossref
|b American Society for Biochemistry & Molecular Biology (ASBMB)
|c 2018-04-26
264 _ 1 |3 print
|2 Crossref
|b American Society for Biochemistry & Molecular Biology (ASBMB)
|c 2018-06-08
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1588085759_27570
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Epithelial cell-adhesion molecule (EpCAM) is a transmembrane protein that regulates cell cycle progression and differentiation and is overexpressed in many carcinomas. The EpCAM-induced mitogenic cascade is activated via regulated intramembrane proteolysis (RIP) of EpCAM by ADAM and γ-secretases, generating the signaling-active intracellular domain EpICD. Because of its expression pattern and molecular function, EpCAM is a valuable target in prognostic and therapeutic approaches for various carcinomas. So far, several immunotherapeutic strategies have targeted the extracellular domain of EpCAM. However, targeting the intracellular signaling cascade of EpCAM holds promise for specifically interfering with EpCAM's proliferation-stimulating signaling cascade. Here, using a yellow fluorescence protein-tagged version of the C-terminal fragment of EpCAM, we established a high-content screening (HCS) of a small-molecule compound library (n = 27,280) and characterized validated hits that target EpCAM signaling. In total, 128 potential inhibitors were initially identified, of which one compound with robust inhibitory effects on RIP of EpCAM was analyzed in greater detail. In summary, our study demonstrates that the development of an HCS for small-molecule inhibitors of the EpCAM signaling pathway is feasible. We propose that this approach may also be useful for identifying chemical compounds targeting other disorders involving membrane cleavage-dependent signaling pathways.
536 _ _ |a 342 - Disease Mechanisms and Model Systems (POF3-342)
|0 G:(DE-HGF)POF3-342
|c POF3-342
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed,
650 _ 7 |a Epithelial Cell Adhesion Molecule
|2 NLM Chemicals
650 _ 7 |a Small Molecule Libraries
|2 NLM Chemicals
650 _ 2 |a Cell Proliferation: drug effects
|2 MeSH
650 _ 2 |a Drug Evaluation, Preclinical: methods
|2 MeSH
650 _ 2 |a Epithelial Cell Adhesion Molecule: antagonists & inhibitors
|2 MeSH
650 _ 2 |a Epithelial Cell Adhesion Molecule: metabolism
|2 MeSH
650 _ 2 |a HEK293 Cells
|2 MeSH
650 _ 2 |a High-Throughput Screening Assays: methods
|2 MeSH
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Signal Transduction: drug effects
|2 MeSH
650 _ 2 |a Small Molecule Libraries: chemistry
|2 MeSH
650 _ 2 |a Small Molecule Libraries: pharmacology
|2 MeSH
650 _ 2 |a Transcription, Genetic: drug effects
|2 MeSH
700 1 _ |a Schorpp, Kenji
|b 1
700 1 _ |a Luxenburger, Elke
|b 2
700 1 _ |a Trambauer, Johannes
|b 3
700 1 _ |a Steiner, Harald
|0 P:(DE-2719)2000023
|b 4
|u dzne
700 1 _ |a Hadian, Kamyar
|b 5
700 1 _ |a Gires, Olivier
|0 P:(DE-HGF)0
|b 6
|e Corresponding author
700 1 _ |a Niessing, Dierk
|b 7
773 1 8 |a 10.1074/jbc.ra118.002776
|b : American Society for Biochemistry & Molecular Biology (ASBMB), 2018-04-26
|n 23
|p 8994-9005
|3 journal-article
|2 Crossref
|t Journal of Biological Chemistry
|v 293
|y 2018
|x 0021-9258
773 _ _ |a 10.1074/jbc.RA118.002776
|g Vol. 293, no. 23, p. 8994 - 9005
|0 PERI:(DE-600)1474604-9
|n 23
|q 293:23<8994 - 9005
|p 8994-9005
|t The journal of biological chemistry
|v 293
|y 2018
|x 0021-9258
856 7 _ |2 Pubmed Central
|u http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5995519
909 C O |o oai:pub.dzne.de:140001
|p VDB
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 4
|6 P:(DE-2719)2000023
913 1 _ |a DE-HGF
|b Forschungsbereich Gesundheit
|l Erkrankungen des Nervensystems
|1 G:(DE-HGF)POF3-340
|0 G:(DE-HGF)POF3-342
|2 G:(DE-HGF)POF3-300
|v Disease Mechanisms and Model Systems
|x 0
914 1 _ |y 2018
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b J BIOL CHEM : 2019
|d 2021-05-04
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2021-05-04
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2021-05-04
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0320
|2 StatID
|b PubMed Central
|d 2021-05-04
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2021-05-04
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2021-05-04
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2021-05-04
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2021-05-04
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2021-05-04
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2021-05-04
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
|d 2021-05-04
920 1 _ |0 I:(DE-2719)1110000-1
|k AG Steiner
|l Biochemistry of γ-Secretase
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-2719)1110000-1
980 _ _ |a UNRESTRICTED
999 C 5 |a 10.1083/jcb.125.2.437
|9 -- missing cx lookup --
|2 Crossref
|o 10.1083/jcb.125.2.437
999 C 5 |a 10.1073/pnas.91.13.5833
|9 -- missing cx lookup --
|2 Crossref
|o 10.1073/pnas.91.13.5833
999 C 5 |a 10.1073/pnas.86.1.27
|9 -- missing cx lookup --
|2 Crossref
|o 10.1073/pnas.86.1.27
999 C 5 |a 10.1073/pnas.87.9.3542
|9 -- missing cx lookup --
|2 Crossref
|o 10.1073/pnas.87.9.3542
999 C 5 |a 10.1152/ajpgi.00069.2014
|9 -- missing cx lookup --
|2 Crossref
|o 10.1152/ajpgi.00069.2014
999 C 5 |2 Crossref
|o
999 C 5 |a 10.1038/sj.bjc.6603494
|9 -- missing cx lookup --
|2 Crossref
|o 10.1038/sj.bjc.6603494
999 C 5 |a 10.3109/15419069409004452
|9 -- missing cx lookup --
|2 Crossref
|o 10.3109/15419069409004452
999 C 5 |a 10.1038/sj.onc.1207610
|9 -- missing cx lookup --
|2 Crossref
|o 10.1038/sj.onc.1207610
999 C 5 |a 10.1038/ncb1824
|9 -- missing cx lookup --
|2 Crossref
|o 10.1038/ncb1824
999 C 5 |a 10.1158/1541-7786.MCR-12-0518
|9 -- missing cx lookup --
|2 Crossref
|o 10.1158/1541-7786.MCR-12-0518
999 C 5 |a 10.1074/jbc.M109.077081
|9 -- missing cx lookup --
|2 Crossref
|o 10.1074/jbc.M109.077081
999 C 5 |a 10.1038/onc.2016.504
|9 -- missing cx lookup --
|2 Crossref
|o 10.1038/onc.2016.504
999 C 5 |a 10.1038/onc.2012.75
|9 -- missing cx lookup --
|2 Crossref
|o 10.1038/onc.2012.75
999 C 5 |a 10.1038/srep41852
|9 -- missing cx lookup --
|2 Crossref
|o 10.1038/srep41852
999 C 5 |a 10.1038/s41598-018-20131-8
|9 -- missing cx lookup --
|2 Crossref
|o 10.1038/s41598-018-20131-8
999 C 5 |a 10.1002/ijc.10270
|9 -- missing cx lookup --
|2 Crossref
|o 10.1002/ijc.10270
999 C 5 |a 10.1023/B:BREA.0000036787.59816.01
|9 -- missing cx lookup --
|2 Crossref
|o 10.1023/B:BREA.0000036787.59816.01
999 C 5 |a 10.2353/ajpath.2007.070152
|9 -- missing cx lookup --
|2 Crossref
|o 10.2353/ajpath.2007.070152
999 C 5 |a 10.1002/stem.97
|9 -- missing cx lookup --
|2 Crossref
|o 10.1002/stem.97
999 C 5 |a 10.1002/stem.221
|9 -- missing cx lookup --
|2 Crossref
|o 10.1002/stem.221
999 C 5 |a 10.1002/jcp.26286
|9 -- missing cx lookup --
|2 Crossref
|o 10.1002/jcp.26286
999 C 5 |a 10.1084/jem.20061603
|9 -- missing cx lookup --
|2 Crossref
|o 10.1084/jem.20061603
999 C 5 |a 10.1007/s001099900038
|9 -- missing cx lookup --
|2 Crossref
|o 10.1007/s001099900038
999 C 5 |a 10.1016/j.humpath.2003.08.026
|9 -- missing cx lookup --
|2 Crossref
|o 10.1016/j.humpath.2003.08.026
999 C 5 |a 10.1038/nrc2521-c2, 10.1038/nrc2521-c1, 10.1038/nrc2499-c2, 10.1038/nrc2499-c1
|9 -- missing cx lookup --
|2 Crossref
|o 10.1038/nrc2521-c2, 10.1038/nrc2521-c1, 10.1038/nrc2499-c2, 10.1038/nrc2499-c1
999 C 5 |a 10.1016/j.gene.2011.04.005
|9 -- missing cx lookup --
|2 Crossref
|o 10.1016/j.gene.2011.04.005
999 C 5 |a 10.1038/modpathol.3800733
|9 -- missing cx lookup --
|2 Crossref
|o 10.1038/modpathol.3800733
999 C 5 |a 10.1016/j.oraloncology.2006.10.010
|9 -- missing cx lookup --
|2 Crossref
|o 10.1016/j.oraloncology.2006.10.010
999 C 5 |a 10.1186/1471-2407-10-331
|9 -- missing cx lookup --
|2 Crossref
|o 10.1186/1471-2407-10-331
999 C 5 |a 10.1371/journal.pone.0014130
|9 -- missing cx lookup --
|2 Crossref
|o 10.1371/journal.pone.0014130
999 C 5 |a 10.1136/jcp.2007.049460
|9 -- missing cx lookup --
|2 Crossref
|o 10.1136/jcp.2007.049460
999 C 5 |a 10.1136/jcp.2006.037333
|9 -- missing cx lookup --
|2 Crossref
|o 10.1136/jcp.2006.037333
999 C 5 |a 10.1016/j.cell.2009.11.025
|9 -- missing cx lookup --
|2 Crossref
|o 10.1016/j.cell.2009.11.025
999 C 5 |a 10.1038/bjc.2014.366
|9 -- missing cx lookup --
|2 Crossref
|o 10.1038/bjc.2014.366
999 C 5 |a 10.1242/dev.091538
|9 -- missing cx lookup --
|2 Crossref
|o 10.1242/dev.091538
999 C 5 |a 10.1093/carcin/bgq187
|9 -- missing cx lookup --
|2 Crossref
|o 10.1093/carcin/bgq187
999 C 5 |a 10.1158/1078-0432.CCR-03-0528
|9 -- missing cx lookup --
|2 Crossref
|o 10.1158/1078-0432.CCR-03-0528
999 C 5 |a 10.3892/or.2016.4789
|9 -- missing cx lookup --
|2 Crossref
|o 10.3892/or.2016.4789
999 C 5 |a 10.1097/01.pas.0000.146028.70868.7a
|9 -- missing cx lookup --
|2 Crossref
|o 10.1097/01.pas.0000.146028.70868.7a
999 C 5 |a 10.1158/0008-5472.CAN-16-0842
|9 -- missing cx lookup --
|2 Crossref
|o 10.1158/0008-5472.CAN-16-0842
999 C 5 |a 10.1007/s00432-009-0569-5
|9 -- missing cx lookup --
|2 Crossref
|o 10.1007/s00432-009-0569-5
999 C 5 |a 10.1158/0008-5472.CAN-09-0654
|9 -- missing cx lookup --
|2 Crossref
|o 10.1158/0008-5472.CAN-09-0654
999 C 5 |y 1989
|2 Crossref
|o Strnad 1989
999 C 5 |a 10.1074/jbc.M008839200
|9 -- missing cx lookup --
|2 Crossref
|o 10.1074/jbc.M008839200
999 C 5 |a 10.1111/j.1432-1033.1996.0125h.x
|9 -- missing cx lookup --
|2 Crossref
|o 10.1111/j.1432-1033.1996.0125h.x
999 C 5 |a 10.1186/1471-2407-9-402
|9 -- missing cx lookup --
|2 Crossref
|o 10.1186/1471-2407-9-402
999 C 5 |a 10.1016/j.mam.2008.08.001
|9 -- missing cx lookup --
|2 Crossref
|o 10.1016/j.mam.2008.08.001
999 C 5 |a 10.1074/jbc.M115.662700
|9 -- missing cx lookup --
|2 Crossref
|o 10.1074/jbc.M115.662700
999 C 5 |a 10.1038/sj.onc.1210057
|9 -- missing cx lookup --
|2 Crossref
|o 10.1038/sj.onc.1210057
999 C 5 |a 10.4161/cam.18953
|9 -- missing cx lookup --
|2 Crossref
|o 10.4161/cam.18953
999 C 5 |a 10.1038/sj.bjc.6604725
|9 -- missing cx lookup --
|2 Crossref
|o 10.1038/sj.bjc.6604725
999 C 5 |a 10.1186/1475-2867-10-44
|9 -- missing cx lookup --
|2 Crossref
|o 10.1186/1475-2867-10-44
999 C 5 |a 10.1177/002215540104900711
|9 -- missing cx lookup --
|2 Crossref
|o 10.1177/002215540104900711
999 C 5 |a 10.1158/1078-0432.CCR-11-2767
|9 -- missing cx lookup --
|2 Crossref
|o 10.1158/1078-0432.CCR-11-2767
999 C 5 |a 10.1097/CJI.0b013e3181826d89
|9 -- missing cx lookup --
|2 Crossref
|o 10.1097/CJI.0b013e3181826d89
999 C 5 |a 10.1007/s11523-013-0290-9
|9 -- missing cx lookup --
|2 Crossref
|o 10.1007/s11523-013-0290-9
999 C 5 |a 10.4161/mabs.28207
|9 -- missing cx lookup --
|2 Crossref
|o 10.4161/mabs.28207
999 C 5 |a 10.18632/oncotarget.12073
|9 -- missing cx lookup --
|2 Crossref
|o 10.18632/oncotarget.12073
999 C 5 |a 10.1016/S0140-6736(82)91811-6
|9 -- missing cx lookup --
|2 Crossref
|o 10.1016/S0140-6736(82)91811-6
999 C 5 |y 1984
|2 Crossref
|o Sears 1984
999 C 5 |a 10.1200/JCO.2008.18.5710
|9 -- missing cx lookup --
|2 Crossref
|o 10.1200/JCO.2008.18.5710
999 C 5 |a 10.1200/JCO.2008.20.6284
|9 -- missing cx lookup --
|2 Crossref
|o 10.1200/JCO.2008.20.6284
999 C 5 |a 10.4161/mabs.2.2.11221
|9 -- missing cx lookup --
|2 Crossref
|o 10.4161/mabs.2.2.11221
999 C 5 |a 10.18632/oncotarget.4453
|9 -- missing cx lookup --
|2 Crossref
|o 10.18632/oncotarget.4453
999 C 5 |a 10.1159/000343863
|9 -- missing cx lookup --
|2 Crossref
|o 10.1159/000343863
999 C 5 |a 10.1371/journal.pone.0071836
|9 -- missing cx lookup --
|2 Crossref
|o 10.1371/journal.pone.0071836
999 C 5 |a 10.1093/embo-reports/kve180
|9 -- missing cx lookup --
|2 Crossref
|o 10.1093/embo-reports/kve180
999 C 5 |a 10.1093/nar/29.9.e45
|9 -- missing cx lookup --
|2 Crossref
|o 10.1093/nar/29.9.e45
999 C 5 |a 10.1177/108705719900400206
|9 -- missing cx lookup --
|2 Crossref
|o 10.1177/108705719900400206


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21